Feed Editor (Unlicensed) 8 Aug 2012 00:07:24 GMT Merck.com - Company Statements Merck.com - Company Statements http://www.merck.com/newsroom/company-statements/ http://www.merck.com/site_images/mercklogo-rss.jpg http://www.merck.com/newsroom/company-statements/ Merck.com - Company Statements Merck Statement On NASONEX® (mometasone furoate monohydrate) Patent Trial in the U.S. District Court for the District of New Jersey 4 Apr 2012 19:28:41 GMT http://www.merck.com/newsroom/company-statements/2012_0404.html DB8D5327-776D-4CF8-BE99-BDB72BF52EB8 Merck Provides Update on IMPROVE-IT Trial 29 Mar 2012 00:07:24 GMT http://www.merck.com/newsroom/company-statements/2012_0328.html?src=rss 5F911DAF-BF77-4690-9710-12B7AE1A9237 Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas 21 Mar 2012 00:07:31 GMT http://www.merck.com/newsroom/company-statements/2012_0320.html?src=rss 2175B6F3-2A17-4ACC-A04D-148EC0BD4ECC Merck Provides U.S. Regulatory Update on Investigational Ezetimibe/Atorvastatin Tablets 5 Mar 2012 19:29:35 GMT http://www.merck.com/newsroom/company-statements/2012_0305.html Merck Provides Information on FDA Post-Marketing Requirement for Sitagliptin 28 Feb 2012 19:26:03 GMT http://www.merck.com/newsroom/company-statements/2012_0228.html?src=rss 570DB35F-F8EA-4197-A7CB-CA7FBD48F92C Merck Statement on GARDASIL 13 Sep 2011 05:00:00 GMT http://www.merck.com/newsroom/company-statements/2011_0913a.html?src=rss 5928437F-749D-41E4-A64A-C54248B338A3 Merck Provides Update on the IMPROVE-IT Trial 13 Sep 2011 05:00:00 GMT http://www.merck.com/newsroom/company-statements/2011_0913.html?src=rss CFEF00F2-BF56-4AD4-A123-35CDD4B994AC Merck Statement on Voluntary Submission of Clinical Research Protocols for its Investigational and Approved Products 2 Jul 2011 00:07:35 GMT http://www.merck.com/newsroom/company-statements/2011_0701.html?src=rss 5084B18E-4CB0-4F54-ABBF-4C8B9C1283C2 Merck Statement on Investigation of PCV Presented at Advisory Committee on Immunization Practices Meeting 28 Oct 2010 05:00:00 GMT http://www.merck.com/newsroom/company-statements/2010_1028.html?src=rss 506D8854-8FAA-4F81-A0A2-FCA2728F9167